ROY F CHEMALY to Placebos
This is a "connection" page, showing publications ROY F CHEMALY has written about Placebos.
Connection Strength
0.133
-
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Infect Dis. 2011 Apr; 11(4):284-92.
Score: 0.091
-
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation. Antimicrob Agents Chemother. 2020 03 24; 64(4).
Score: 0.042